Policy & Regulatory Updates
-
Amazon Care, Health Systems & Home Care Companies Launch ‘Moving Health Home’ Hospital-At-Home Health Care Alliance
Market Watch | March 10, 2021 -
Blue Cross & Blue Shield Of Minnesota Extends Additional Virtual Care Benefits Through End Of 2021
Market Watch | February 23, 2021 -
Spring Arbor University Launches New Online MSN-NP Specializations In Psychiatric-Mental Health & Pediatric Primary Care
Market Watch | February 23, 2021 -
President Biden Signs Executive Order To Open Special Three-Month Enrollment Period For Healthcare.gov Starting February 15, 2021
Market Watch | February 10, 2021 -
HRSA Designates Centerstone Health Services As A Federally Qualified Health Center Look-Alike
Market Watch | February 3, 2021 -
AmeriHealth Caritas Louisiana Selected To Participate In Medicare Primary Care First Direct Contracting Initiative
Market Watch | February 3, 2021 -
South Carolina Adds Humana As MCO For Healthy Connections Medicaid & Healthy Connections Prime Programs
Market Watch | February 2, 2021 -
Signify Health Files Registration Statement For Proposed Initial Public Offering
Market Watch | January 25, 2021 -
North Carolina Awards Contract For Medicaid Managed Care Ombudsman Services To Legal Aid Of North Carolina
Market Watch | January 25, 2021 -
HHS Extends COVID-19 Public Health Emergency Into April 2021
Market Watch | January 21, 2021 -
Hennepin Healthcare System Settles EEOC Age Discrimination Complaint
Market Watch | January 20, 2021 -
Tennessee Approves Certificate Of Need For Geriatric Psychiatric Hospital, Natchez Center For Behavioral Medicine, In Dickson
Market Watch | January 14, 2021 -
UPMC Center for High-Value Health Care Receives $3.76 Million PCORI Award to Improve Digital & In-Person Access To Behavioral Health Care For Moms On Medicaid
Market Watch | January 13, 2021 -
STALICLA Translates Its Novel Precision Medicine Approach For Autism Spectrum Disorder Into Clinical Development In Phase 1b Trial Of STP1
Market Watch | January 13, 2021 -
FDA Accepts Alkermes’ Resubmission Of New Drug Application For ALKS 3831 As Treatment For Schizophrenia & Bipolar Disorder
Market Watch | January 13, 2021